<DOC>
	<DOCNO>NCT01801085</DOCNO>
	<brief_summary>This prospective time-and-motion study document compare time use preparation , dispense administration capecitabine/oxaliplatin ( XELOX ) versus IV 5-FU/leucovorin/oxaliplatin ( FOLFOX4 ) regimens colorectal cancer ( CRC ) patient .</brief_summary>
	<brief_title>Nursing Pharmacy Time Delivering XelodaÂ® Versus 5-Fluoruracil Regimens</brief_title>
	<detailed_description>Colorectal cancer ( CRC ) second common cause cancer-related death Hong Kong . The traditional chemotherapy CRC remain intravenous ( IV ) fluorouracil ( 5-FU ) base regimens response rate 10-20 % median survival approximately one year . Recent year , oral chemotherapy practical economic advantage IV regimen . It understandable patient prefer oral regimen long clinical efficacy maintain . Oral treatment strategy preserve quality life CRC patient . In previous cost-minimization study conduct Hong Kong , demonstrate capecitabine cost-effective 5-FU plus oxaliplatin assume equal clinical efficacy . Not capecitabine cost-effective , may also additional cost save nurse pharmacy time . It significant amount time save nursing pharmacy preparation administration IV chemotherapy . In UK , demonstrate capecitabine require less pharmacy administration time per cycle 5-FU base IV chemotherapy . However , lack local data demonstrate impact pharmacy nurse care utilize capecitabine compare traditional IV chemotherapy CRC patient Hong Kong .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Age 18 Diagnosed CRC prescribe either XELOX FOLFOX4 chemotherapy treatment Patients le 18 year age Persons relate unequally investigator Patients mentally/cognitively disable Patients refuse give consent participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Time-and-Motion</keyword>
	<keyword>Neoplasm</keyword>
	<keyword>Colorectal Cancer</keyword>
</DOC>